Last edition
News about Drug Discovery & Development
Imugene and JW Therapeutics have partnered to explore a new combination for refractory solid tumours, pairing Imugene’s onCARlytics (CF33-CD19) oncolytic virus with JW’s CD19 CAR-T therapy, Carteyva. The collaboration will begin with pre-clinical studies and advance to a Phase 1 investigator-initiated trial in China targeting hard-to-treat cancers.
Drug Discovery & Development | 01/12/2025 | By Dineshwori | 280
Zydus Pharma Secures USFDA Approval for Generic Hypertension Drug
Zydus Lifesciences announced that it has received final approval from the United States Food and Drug Administration to market Telmisartan tablets, a generic version of a commonly prescribed blood pressure medication.
Drug Discovery & Development | 26/11/2025 | By Darshana | 407
Alkem Launches De Simone Formulation Probiotic DSS in India
Alkem Laboratories has introduced DSS, the original De Simone formulation probiotic blend, to the Indian market for restoring gut microbiota balance and managing a wide range of gastrointestinal conditions.
Drug Discovery & Development | 24/11/2025 | By Darshana | 862
HRV Pharma, MetroChem Form Multi-Year CDMO Alliance for High-Value API Development
HRV Global Life Sciences (HRV Pharma), India’s first integrated virtual API and pharmtech company, has entered into a multi-year CDMO partnership with MetroChem API, a leading player in API development and manufacturing.
Drug Discovery & Development | 19/11/2025 | By Darshana | 409
Alembic Secures US FDA Approval for Migraine Treatment Autoinjector
The approved product is therapeutically equivalent to the reference-listed drug, Imitrex STATdose System, priorly marketed by GlaxoSmithKline.
Drug Discovery & Development | 11/11/2025 | By Darshana | 267
ClearPoint Neuro Acquires IRRAS to Boost Neuro Drug Delivery Portfolio
Its cornerstone product is the IRRAflow system, a US FDA-cleared and CE-marked platform which integrates continuous irrigation, aspiration, and real-time intracranial pressure monitoring.
Drug Discovery & Development | 10/11/2025 | By Darshana | 457
US FDA Grants Six More Priority Review Vouchers to Accelerate Drug Approvals
The US Food and Drug Administration (FDA) has awarded six additional companies under its “Commissioner’s National Priority Voucher” programme, bringing the total number of recipients to fifteen.
Drug Discovery & Development | 07/11/2025 | By Darshana | 269
Nona Biosciences and Umoja Biopharma Expand Partnership to Advance In-vivo CAR-T Therapies
Under the terms of the agreement, Nona Biosciences is eligible to receive an upfront payment, potential option exercise fees and milestone payments tied to the discovery and development of specific programmes in the collaboration. Umoja will be responsible for all further product development and commercialisation.
Drug Discovery & Development | 07/11/2025 | By Dineshwori | 477
Researchers from the Indian Institute of Technology Madras (IIT Madras) and Ohio State University have developed an advanced artificial intelligence framework that replicates real-world chemical synthesis to accelerate drug discovery.
Drug Discovery & Development | 06/11/2025 | By Darshana | 376
AmacaThera, a leading biotechnology company specialising in next-generation hydrogel-based drug delivery systems, has entered into an exclusive global licensing agreement with Pacira BioSciences, Inc., a leader in non-opioid pain management, to develop and commercialise AMT-143.
Drug Discovery & Development | 05/11/2025 | By Darshana | 231
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy